These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3078949

  • 1. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
    Eick D, Polack A, Kofler E, Bornkamm GW.
    Oncogene; 1988 Oct; 3(4):397-403. PubMed ID: 3078949
    [Abstract] [Full Text] [Related]

  • 2. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ, Kohlhuber F, Mautner J, Polack A, Eick D.
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [Abstract] [Full Text] [Related]

  • 3. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A, Strobl L, Feederle R, Schweizer M, Koch E, Eick D, Wiegand H, Bornkamm GW.
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [Abstract] [Full Text] [Related]

  • 4. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
    Arasi VE, Lieberman R, Sandlund J, Kiwanuka J, Novikovs L, Kirsch I, Hollis G, Magrath IT.
    Cancer Res; 1989 Jun 15; 49(12):3235-41. PubMed ID: 2497974
    [Abstract] [Full Text] [Related]

  • 5. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters.
    Kohlhuber F, Strobl LJ, Eick D.
    Oncogene; 1993 Apr 15; 8(4):1099-102. PubMed ID: 8455938
    [Abstract] [Full Text] [Related]

  • 6. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression.
    Re GG, Antoun GR, Zipf TF.
    Oncogene; 1990 Aug 15; 5(8):1247-50. PubMed ID: 1697411
    [Abstract] [Full Text] [Related]

  • 7. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
    Darling D, Tavassoli M, Linskens MH, Farzaneh F.
    Oncogene; 1989 Feb 15; 4(2):175-9. PubMed ID: 2648255
    [Abstract] [Full Text] [Related]

  • 8. The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles.
    Spencer CA, LeStrange RC, Novak U, Hayward WS, Groudine M.
    Genes Dev; 1990 Jan 15; 4(1):75-88. PubMed ID: 2307371
    [Abstract] [Full Text] [Related]

  • 9. Expression of P0- and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells.
    Eick D, Polack A, Kofler E, Lenoir GM, Rickinson AB, Bornkamm GW.
    Oncogene; 1990 Sep 15; 5(9):1397-402. PubMed ID: 2216463
    [Abstract] [Full Text] [Related]

  • 10. The role of immunoglobulin kappa elements in c-myc activation.
    Hörtnagel K, Mautner J, Strobl LJ, Wolf DA, Christoph B, Geltinger C, Polack A.
    Oncogene; 1995 Apr 06; 10(7):1393-401. PubMed ID: 7731690
    [Abstract] [Full Text] [Related]

  • 11. c-myc and c-fos gene regulation during mouse liver regeneration.
    Sobczak J, Mechti N, Tournier MF, Blanchard JM, Duguet M.
    Oncogene; 1989 Dec 06; 4(12):1503-8. PubMed ID: 2512526
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
    Jochner N, Eick D, Zimber-Strobl U, Pawlita M, Bornkamm GW, Kempkes B.
    EMBO J; 1996 Jan 15; 15(2):375-82. PubMed ID: 8617212
    [Abstract] [Full Text] [Related]

  • 13. Analysis of c-myc expression in a human hepatoma cell line.
    Huber BE, Thorgeirsson SS.
    Cancer Res; 1987 Jul 01; 47(13):3414-20. PubMed ID: 3034414
    [Abstract] [Full Text] [Related]

  • 14. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells.
    Bentley DL, Groudine M.
    Nature; 1987 Jul 01; 321(6071):702-6. PubMed ID: 3520340
    [Abstract] [Full Text] [Related]

  • 15. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R, Nepveu A, Marcu KB, McBurney MW.
    Oncogene; 1988 Nov 01; 3(5):553-9. PubMed ID: 3078960
    [Abstract] [Full Text] [Related]

  • 16. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
    Gerbitz A, Mautner J, Geltinger C, Hörtnagel K, Christoph B, Asenbauer H, Klobeck G, Polack A, Bornkamm GW.
    Oncogene; 1999 Mar 04; 18(9):1745-53. PubMed ID: 10208435
    [Abstract] [Full Text] [Related]

  • 17. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
    Wilda M, Busch K, Klose I, Keller T, Woessmann W, Kreuder J, Harbott J, Borkhardt A.
    Genes Chromosomes Cancer; 2004 Oct 04; 41(2):178-82. PubMed ID: 15287031
    [Abstract] [Full Text] [Related]

  • 18. [Rearrangement of the proto-oncogene c-myc in fresh cells from Burkitt's leukemia (L3)].
    Mathieu-Mahul D, Bernheim A, Berger R, Mauchauffe M, Flandrin G, Larsen CJ.
    Nouv Rev Fr Hematol (1978); 1985 Oct 04; 27(3):157-61. PubMed ID: 2993997
    [Abstract] [Full Text] [Related]

  • 19. Coexistence of a c-myc mRNA initiated in intron 1 with the normal c-myc mRNA and similar regulation of both transcripts in mammalian cells.
    Ray D, Robert-Lézénès J.
    Oncogene Res; 1989 Oct 04; 5(1):73-8. PubMed ID: 2674860
    [Abstract] [Full Text] [Related]

  • 20. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
    Suchy BK, Sarafoff M, Kerler R, Rabes HM.
    Cancer Res; 1989 Dec 01; 49(23):6781-7. PubMed ID: 2684400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.